The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Davidson, Michael H.
One or more keywords matched the following items that are connected to Davidson, Michael H.
Item TypeName
Concept Dyslipidemias
Academic Article Low-density lipoprotein subclass distribution pattern and adiposity-associated dyslipidemia in postmenopausal women.
Academic Article Combination therapy for dyslipidemia: safety and regulatory considerations.
Academic Article Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia.
Academic Article Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.
Academic Article Reducing residual risk for patients on statin therapy: the potential role of combination therapy.
Academic Article Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy.
Academic Article Biologic therapies for dyslipidemia.
Academic Article New concepts in dyslipidemia in the metabolic syndrome and diabetes.
Academic Article Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
Academic Article Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors.
Academic Article Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
Academic Article Combination therapy in the management of complex dyslipidemias.
Academic Article Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy.
Academic Article Treating dyslipidemia in high-risk patients: case reviews and discussion.
Academic Article Management of dyslipidemia in patients with complicated metabolic syndrome.
Academic Article Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
Academic Article Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
Academic Article Squalene synthase inhibition: a novel target for the management of dyslipidemia.
Academic Article Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects.
Academic Article A clinical puzzle: fibrates and homocysteine elevation: editorial to: "fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine" by M. Lever et al.
Academic Article Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey.
Academic Article Achieving optimal lipid values in patients with dyslipidemia is associated with reduced risk of cardiovascular events.
Academic Article Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies.
Academic Article The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review.
Academic Article Targeting high-density lipoprotein cholesterol in the management of cardiovascular disease.
Academic Article Niacin therapy: an evolving paradigm for the management of mixed dyslipidemia and low high-density lipoprotein cholesterol. Introduction.
Academic Article Niacin use and cutaneous flushing: mechanisms and strategies for prevention.
Academic Article Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.
Academic Article Drugs in development for management of lipoprotein disorders.
Academic Article One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
Academic Article Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet.
Academic Article Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
Academic Article Pharmacokinetic interactions between statins and fibrates.
Academic Article Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.
Academic Article Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (= 2 mg/L). cmb@bcm.tmc.edu.
Academic Article Safety considerations with fibrate therapy.
Academic Article Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
Academic Article Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
Academic Article Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome.
Academic Article Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids.
Academic Article Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.
Academic Article Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
Academic Article A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
Academic Article Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
Academic Article Pharmacotherapy: Implications of high-dose statin link with incident diabetes.
Academic Article Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.
Academic Article Effect of colesevelam and niacin on low-density lipoprotein cholesterol and glycemic control in subjects with dyslipidemia and impaired fasting glucose.
Academic Article [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary].
Academic Article Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial.
Academic Article Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
Academic Article Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Academic Article Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia.
Academic Article Changing characteristics of statin-related cIMT trials from 1988 to 2006.
Academic Article The future of n-3 polyunsaturated fatty acid therapy.
Academic Article Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia.
Academic Article AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.
Academic Article AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Academic Article Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia.
Academic Article The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients.
Academic Article Can We Cure Atherosclerosis?
Academic Article How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention.
Academic Article PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.
Academic Article Update on PCSK9 therapies for the treatment of dyslipidemia.
Academic Article Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.
Academic Article Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
Academic Article Recent advances and emerging therapies in management of dyslipidemias.
Academic Article How I treat statin-associated side effects in an outpatient setting.
Academic Article Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
Academic Article Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial.
Academic Article Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition.
Search Criteria
  • Dyslipidemias